The American Chemistry Council (ACC) today announced that Mike Abrashoff, former U.S. Navy Commander and leadership expert, will deliver the keynote address at the 2026 Responsible Care® & Sustainability Conference & Expo, taking place April 27-29, 2026, at the Marriott Harbor Beach Resort in Fort Lauderdale, Florida. Abrashoff is known for his transformative leadership as […]

San Francisco, CA, Jan. 13, 2026 (GLOBE NEWSWIRE) — Synheart, a Vancouver technology company focused on ethical, human-centric computing, announced the launch of its Human State Infrastructure (HSI)–a new foundational layer designed to allow modern software systems to represent and interact with human state in real time through standardized, on-device interfaces. Founded by Israel Goytom

Synheart Introduces Human State Infrastructure for Modern Systems A Privacy-Preserving Human State Interface (HSI) That Enables Ethical, Real-Time Human-Aware Computing GlobeNewswire January 13, 2026 San Francisco, CA, Jan. 13, 2026 (GLOBE NEWSWIRE) — Synheart, a Vancouver technology company focused on ethical, human-centric computing, announced the launch of its Human State Infrastructure (HSI)–a new foundational layer

(OtherOTC:NXGB),(OTC US:NXGB), LAS VEGAS, Jan. 13, 2026 (GLOBE NEWSWIRE) — NxGen Brands, Inc. (“NxGen” or the “Company”) (OTC: NXGB), a consumer products and brand development company advancing blockchain-enabled engagement and rewards, today announced an update on its Candy Crew CAND token airdrop campaign hosted on Gleam.io and confirmed that the event will conclude in less

NxGen Brands, Inc. (OTC: NXGB) Provides Update on CAND Airdrop Campaign and Announces Imminent PancakeSwap BSC Pair Launch With Final Bonus CAND Opportunity GlobeNewswire January 13, 2026 LAS VEGAS, Jan. 13, 2026 (GLOBE NEWSWIRE) — NxGen Brands, Inc. (“NxGen” or the “Company”) (OTC: NXGB), a consumer products and brand development company advancing blockchain-enabled engagement and

(Paris:IPN), Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine in first line unfit acute myeloid leukemia PARIS, FRANCE, 13 JANUARY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for IPN60340 in combination with venetoclax

U.S. FDA grants Ipsen's IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia GlobeNewswire January 13, 2026 Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine in first line unfit acute myeloid leukemia PARIS, FRANCE, 13 JANUARY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that

NEW YORK CITY, NY / ACCESS Newswire / January 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nutanix, Inc. ("Nutanix" or "the Company") (NASDAQ:NTNX). Investors who purchased Nutanix securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NTNX. Nutanix

“We wanted to create a new cocktail pick to secure drink garnishes and hors d’oeuvres,” said one of two inventors, from Placentia, Calif., “so we invented the GARNISH MATE. Our design offers an improved alternative to traditional toothpicks.” The patent-pending invention provides a specially designed cocktail pick for various garnishes. In doing so, it easily

Plochingen, Baden-Württemberg, Jan. 13, 2026 (GLOBE NEWSWIRE) — Robinson Consulting, a digital marketing advisory for solo entrepreneurs and companies without marketing departments, reached full client capacity just 90 days after refocusing its service model in mid-2025. The rapid growth came from clients achieving fast, visible results and referring others. Benjamin Robinson, Founder of Robinson Consulting